Sunday, March 26, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Policy + Initiatives

Congress Passes Pandemic All-Hazard Preparedness Act

by Global Biodefense Staff
January 22, 2013

The U.S. House of Representatives today approved the Pandemic and All-Hazards Preparedness Reauthorization Act of 2013, H.R. 307. The legislation, introduced by Rep. Mike Rogers (R-MI), reauthorizes provisions of the Project Bioshield Act of 2004 and Pandemic and All-Hazards Preparedness Act (PAHPA) of 2006 for an additional five years.

H.R. 307 continues to strengthen the nation’s preparedness infrastructure and support development of medical countermeasures to better respond to chemical, biological, radiological, and nuclear attacks.

The bill was brought to vote under a suspension of House rules, a common practice for bills expected to easily obtain at least a two-thirds majority, allowing just 40 minutes of debate prior to a vote. 

Energy and Commerce Committee Chairman Fred Upton (R-MI) said, “I would like to thank Rep. Rogers along with all the other members who worked on this bipartisan bill that will improve the nation’s health infrastructure to help us respond to a terrorist attack and provide additional flexibility for emergency distribution, stockpiling and use of medical countermeasures to ensure the nation is prepared for public health emergencies. As the nation grapples with a severe flu season, the need to pass this legislation is ever more apparent.”

The vote passed by an overwhelming 91 percent majority. Voting against H.R. 307 were 29 House Republicans. No House Democrats voted against the bill.

The full text of H.R. 307 is available here.

Tags: Emerging ThreatsPandemic

Related Posts

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA
Funding News

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Liverpool Synthetic Biology Lab Backed By 2M Award
Policy + Initiatives

Political Interference: White House Launches Framework to Protect Scientific Integrity

January 13, 2023
Much of the CDC is Working Remotely. That Could Make Changing the Agency Difficult.
Policy + Initiatives

Much of the CDC is Working Remotely. That Could Make Changing the Agency Difficult.

December 7, 2022
Study: Cash Incentives and Lotteries Do Little to Increase Adult Vaccinations
Medical Countermeasures

Study: Cash Incentives and Lotteries Do Little to Increase Adult Vaccinations

October 25, 2022
Load More

Latest News

Biodefense Headlines – 26 March 2023

March 26, 2023
Biodefense Headlines – 12 March 2023

Biodefense Headlines – 12 March 2023

March 12, 2023
Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC